Transformed Follicular Lymphoma (TFL) Clinical Trials

14 clinical trials for Transformed Follicular Lymphoma (TFL) across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) — RECRUITING
• Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients — RECRUITING · PHASE1
• Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients — RECRUITING · PHASE1
• CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas — RECRUITING · PHASE1
• P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies — ACTIVE_NOT_RECRUITING · PHASE1
• Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T — COMPLETED · PHASE1
• A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies — NOT_YET_RECRUITING · NA
• Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy — ACTIVE_NOT_RECRUITING · PHASE2
• Clinical Follow-up Study of CD19 CAR-T Expressing IL7 and CCL19 for Relapsed or Refractory B Cell Lymphoma — COMPLETED
• ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) — ACTIVE_NOT_RECRUITING · PHASE1
• CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies — COMPLETED · PHASE1
• Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma — COMPLETED · PHASE1
• Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL — COMPLETED · PHASE1
• MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- Vincristine — COMPLETED · PHASE1

Refine this search